As a function of the restructuring of the company since the end of 2018, Integumen has delivered a nine fold increase in revenue in H1 2019.
The company has also transformed the balance sheet with the disposal of underperforming subsidiaries, the removal of outstanding debt and the acquisition of RinoCloud to augment Integumen’s Labskin business.
With a successful fundraising of £2.75m also completed in April 2019 providing significant working capital, we believe that Integumen is very well placed for continued sales growth in H2 2019.
We would draw your attention to the various disclaimers in the document both at the beginning and at the end of the note. Retail clients (as defined by the rules of the FCA) must not rely on the research document. In particular you should note that the research document is a non-independent marketing communication. The analyst who has prepared the research is aware that TPI provides research to Falanx Group Ltd. Accordingly the research has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibitions on dealing ahead of its dissemination.
The information in the document is published solely for information purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. The material contained in the document is general information intended for recipients who understand the risks associated with equity investment in smaller companies. It does not constitute a personal recommendation as defined by the FCA or take into account the particular investment objectives, financial situation or needs of individual investors nor provide any indication as to whether an investment, a course of action or the associated risks are suitable for the recipient.
RISK WARNING: The value of shares and the income from them may go down as well as up and you may not get back the money you invested. It should not be assumed that the value of investments will always rise. Past performance is not a reliable indicator of future results and any investment in shares carries the risk that all or some of the capital invested might be lost. Investors should carefully consider their own personal financial circumstances before dealing in the stock market and should seek independent professional advice prior to investing. Investors should ensure that they have the financial capacity to bear the risk and only invest money you can afford to lose.
RISK WARNING – INVESTING IN SMALLER COMPANIES: Companies listed on the AIM market can be highly volatile and are considered high risk speculative investments. You should only consider investing in AIM shares if you have an appropriate degree of equity trading knowledge and experience. It may be difficult to sell the shares on a short-term basis without receiving a significantly lower price than you paid. This is the nature of illiquid investments and their large spread.
Turner Pope Investments (TPI) Limited is authorised and regulated by the Financial Conduct Authority (Reference number: 739104). This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you have received this email in error please immediately delete it and all copies of it from your system, destroy any hard copies of it and notify the sender. If this email is not intended for you, you may not copy, distribute or disclose the contents to anyone. Please note that any views or opinions presented in this email are solely those of the author and do not necessarily represent those of Turner Pope Investments (TPI) Limited. The recipient should check this email and any attachments for the presence of viruses. Turner Pope Investments (TPI) Limited accepts no liability for any damage caused by any virus transmitted by this email. Email will be archived for at least three years and may be produced to regulatory agencies or others with a legal right to access such information. Registered address: 8 Frederick’s Place, London, EC2R 8AB. Registered in England and Wales under registered number 09506196.
Copyright © 2019 Turner Pope Investments (TPI) Limited, all rights reserved.
Our mailing address is:
8 Frederick’s Place
In accordance with the 2018 Data Protection Act, Turner Pope Investments (TPI) Limited is committed to protecting your privacy
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned